###begin article-title 0
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
Functional analysis of the novel TBX5 c.1333delC mutation resulting in an extended TBX5 protein
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 205 213 <span type="species:ncbi:9606">patients</span>
###xml 540 547 <span type="species:ncbi:9606">patient</span>
Autosomal dominant Holt-Oram syndrome (HOS) is caused by mutations in the TBX5 gene and is characterized by congenital heart and preaxial radial ray upper limb defects. Most of the TBX5 mutations found in patients with HOS cause premature truncation of the primary TBX5 transcript. TBX5 missense mutations alter the three-dimensional structure of the protein and result in failed nuclear localization or reduced binding to target DNA. In this study we present our functional analyses of the novel and unusual c.1333delC mutation found in a patient with classical HOS.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
The functional impact of this novel mutation was assessed by investigating the intracellular localization of the resulting TBX5 protein and its ability to activate the expression of its downstream target ANF.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
The deletion of the cytosine is the first TBX5 frameshift mutation predicted to result in an elongated TBX5 protein with 74 miscoding amino acids and 62 supernumerary C-terminal amino acids. The c.1333delC mutation affects neither the nuclear localization, nor its colocalization with SALL4, but severely affects the activation of the ANF promoter.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
The mutation c.1333delC does not locate within functional domains, but impairs the activation of the downstream target. This suggests that misfolding of the protein prevents its biological function.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 793 794 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 951 952 951 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 994 999 994 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 1107 1108 1107 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1007 1015 <span type="species:ncbi:9606">patients</span>
Holt-Oram syndrome (HOS) is an autosomal-dominantly inherited disorder caused by mutations in the gene coding for the T-box transcription factor TBX5, which is located on chromosome 12q24 [1,2]. Clinical features are highly penetrant congenital skeletal malformations of the upper limbs associated with variable cardiac anomalies including ASD, VSD, AVSD, PDA, tetralogy of Fallot, heart conduction failure and pulmonary vein anomalies [3]. To date, more than 60 different germline TBX5 gene mutations have been described (TBX5 gene mutation database; ) [4]. A vast majority of these mutations (nonsense, frameshift and splice site mutations) result in preterminal stop codons leading to truncated nonfunctional proteins. Also larger deletions spanning one or more exons have been reported [5,6]. Nonsyndromic germline mutations are not known [7], but somatic mutations (exclusively missense mutations) were found in non-HOS related malformed hearts [8]. The detection rate of mutations in the TBX5 gene in patients with familial or sporadic HOS is 74% following application of stringent clinical criteria [9].
###end p 11
###begin p 12
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf10 </italic>
###xml 454 460 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf10 </italic>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 642 647 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 329 334 <span type="species:ncbi:10090">mouse</span>
TBX5 contains a T-box motif involved in DNA-binding and protein-protein interactions, and operates as a transcriptional activator [10,11]. Mutations within the T-box affect DNA-binding and interaction with NKX2-5, resulting in reduced activation of downstream targets in the cardiac conduction system development [12,13]. In the mouse, Tbx5 controls Fgf10 expression in a synergistic manner together with Sall4 in the forelimbs via direct effects on the Fgf10 promoter [14]. This cooperative action of Tbx5 and Sall4 can be counteracted by Tbx2 and Tbx3. Furthermore, TBX5 was shown to interact with GATA4. Specific missense mutations within TBX5 abrogate this interaction and cause cardiac septal defects [15]. Transactivation of TBX5 is promoted by TAZ, a protein complexing TBX5 and interacting with the histone acetyltransferase p300 [16]. During embryogenesis TBX5 localizes to cellular nuclei. The protein transport is mediated by two distinct, evolutionary conserved nuclear localization signals (NLS) acting cooperatively [17]. Missense mutations within these conserved sequences impair nuclear localization and cause "functional" haploinsufficiency due to decreased protein concentration at the location of its biological function [13].
###end p 12
###begin p 13
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 102 109 <span type="species:ncbi:9606">patient</span>
Here we report on the results of functional analyses of a de novo c.1333delC mutation identified in a patient with sporadic HOS. This mutation does not impair nuclear localization or co-localization with SALL4, but abrogates activation of the ANF promoter.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Case report
###end title 15
###begin p 16
###xml 38 39 38 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 150 156 150 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A, 1C</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 24 31 <span type="species:ncbi:9606">patient</span>
The now 4-year old male patient (Fig. 1) presented with typical manifestations of Holt-Oram syndrome: bilateral hypoplastic clavicles and radii (Fig. 1A, 1C), bilateral triphalangeal thumbs (Fig. 1B), total ASD and muscular VSD, bradycardia due to atrioventricular block requiring pacemaker, hypoplastic lung and pulmonary veins on the right side. He also had micrognathia and a long philtrum. Mental development is normal up to now.
###end p 16
###begin p 17
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The patient</bold>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 17 24 <span type="species:ncbi:9606">patient</span>
The patient. The patient presents bilateral hypoplastic clavicles and radii (A and C) and bilateral triphalangeal thumbs (B). Bradycardia due to atrioventricular block necessitates a pacemaker.
###end p 17
###begin title 18
Genetic analysis
###end title 18
###begin p 19
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 107 114 <span type="species:ncbi:9606">patient</span>
After obtaining informed consent, genomic DNA was extracted from peripheral blood lymphocytes of the index patient and his unaffected parents according to standard protocols. Mutation analysis of the coding sequence of the TBX5 gene including exon-intron boundaries was performed by direct DNA sequencing as described [18].
###end p 19
###begin title 20
Plasmids
###end title 20
###begin p 21
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 244 248 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 354 357 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 415 419 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 425 429 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BamH</italic>
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 613 621 <span type="species:ncbi:9606">Children</span>
TBX5 expression constructs were generated by PCR amplification using the commercially available human full-length cDNA clone (IRATp970D0542D, RZPD, Berlin, Germany). The sequence of the constructs was verified by automated sequencing (ABI Prism(R) 3100 Genetic Analyzer, Applied Biosystems, Darmstadt, Germany). PCR fragments were subcloned into the pGEM(R)-T-Easy vector (Promega, Madison, WI, USA), digested with EcoRI and BamHI and subsequently cloned into the pEGFP-N3/pFLAG-N3 vectors (BD Biosciences, Mountain View, CA, USA). The ANF-luciferase vector was a kind gift from Benoit Bruneau (Hospital for Sick Children, Toronto, Canada).
###end p 21
###begin title 22
Generation of the c.1333delC mutation
###end title 22
###begin p 23
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
The TBX5 construct carrying the c.1333delC mutation was generated with the QuikChangetrade mark Site-directed Mutagenesis kit (Stratagene, La Jolla, CA, USA). Successful incorporation of the mutations was confirmed by automated sequencing.
###end p 23
###begin title 24
Cell culture
###end title 24
###begin p 25
###xml 68 72 <span type="species:ncbi:9913">Calf</span>
COS-7 cells were grown in Minimal essential Medium (MEM), 10% Fetal Calf Serum, 100 mug/ml penicillin, 100 mug/ml streptomycin, 1x MEM nonessential amino acids (all purchased from Invitrogen, Carlsbad, CA, USA) and maintained in a humidified environment with 5% carbon dioxide.
###end p 25
###begin title 26
Intracellular localization
###end title 26
###begin p 27
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 386 390 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 518 523 <span type="species:ncbi:10090">mouse</span>
Co-transfected COS-7 cells were directly seeded on glass coverslips in 24-well plates (1 x 104 cells per plate), washed in PBS after 24 h, fixed with methanol, washed in PBS and blocked for 30 min in 0.5% BSA in IF buffer (10 mM Tris pH 7.5, 300 mM NaCl, 0.05% (v/v) Tween 20). For the detection of intracellular SALL4 localization, coverslips were incubated with a monoclonal anti-FLAG(R) M2 antibody (Stratagene, La Jolla, CA, USA) for 1 h, washed twice with IF buffer and incubated with a fluorescence-labeled anti-mouse IgG (Fab specific)-TRITC antibody for 30 min. Cells were washed three times with IF buffer and mounted on slides with aquamount (BDH Laboratories, Poole, UK). Where indicated, cell nuclei were stained with DAPI blue. The TBX5 distribution pattern could be visualized due to fluorescence of the GFP fusion protein. Cells were analyzed by confocal laser scanning microscopy (CLSM).
###end p 27
###begin title 28
Reporter gene assays
###end title 28
###begin p 29
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 683 702 673 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla reniformis </italic>
###xml 903 908 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 927 930 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ANF</italic>
###xml 634 638 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 683 701 <span type="species:ncbi:6136">Renilla reniformis</span>
The wild type and mutated TBX5 cDNAs were cloned into the mammalian expression vector pFLAG-N3. The reporter construct contained the luciferase gene under the control of the atrial natriuretic factor (ANF) promoter. Each transfection was performed at least in triplicate in 24-well plates and all assays were done with two different DNA preparations of each construct. Transfections of adherent COS-7 cells were carried out at 60-80% confluency using 1 mug Lipofectaminetrade mark2000 reagent (Invitrogen, Carlsbad, CA, USA) per 500 ng transfected DNA. In each transfection an equimolar DNA concentration was used. Control vector pRL-SV40 (Promega, Madison, WI, USA), expressing the Renilla reniformis luciferase, was co-transfected for relativating transfection efficiency at a ratio of 1:100 to the total amount of transfected DNA. In order to analyze the transcriptional regulation capability of the TBX5 constructs, 300 ng ANF-luciferase plasmid and 300 ng TBX5 expression vector were used for co-transfections. DNAs of empty expression vector plasmids were used as negative control. Cell extracts were harvested 24 hours after transfection and dissolved in 125 mul Passive Lysis Buffer (Promega) per well. 20 mul were used to measure luciferase activity according to the Dual Luciferase Assay System Protocol (Promega) using a Lumat LB96P luminometer (Berthold, Bad Wildbad, Germany).
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
Mutation analysis
###end title 31
###begin p 32
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fs</italic>
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 625 633 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 102 109 <span type="species:ncbi:9606">patient</span>
###xml 702 709 <span type="species:ncbi:9606">patient</span>
We identified a novel heterozygous mutation in exon 9 of TBX5 (c.1333delC, p.H445fsX136) in the index patient, but not in his parents. The de novo deletion of the cytosine residue at cDNA position 1333 (codon 445) is predicted to result in a translational frameshift creating not a truncated but an elongated TBX5 protein of 580 amino acids due to a downstream shift of the termination codon to position 581 (normal codon position 519). Thus, the mutant TBX5 protein would contain 74 miscoding amino acids (positions 445 to 518) and 62 supernumerary C-terminal amino acids [see Additional file 1]. These findings suggested a de novo mutational event, which most likely caused Holt-Oram syndrome in our patient. To provide evidence for the pathogenic effect of this special mutation, we carried out further functional investigations.
###end p 32
###begin title 33
c.1333delC does not influence intracellular localization
###end title 33
###begin p 34
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SALL4 </italic>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SALL4 </italic>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 441 447 <span type="species:ncbi:10090">murine</span>
###xml 575 580 <span type="species:ncbi:10090">mouse</span>
The entire coding sequence of human wild type and mutated TBX5 was cloned into the GFP expression plasmid pEGFP-N3, whereas the coding sequence of SALL4 was inserted into the FLAG expression plasmid pFLAG-N3, resulting in TBX5wt-GFP, TBX5mut-GFP and SALL4-FLAG fusion proteins. TBX5 was shown to display a nuclear localization during embryogenesis, thereby having two distinct nuclear localization signals working cooperatively [17,19]. The murine homologue of SALL4 is a nuclear protein localized to heterochromatin and operating as a transcriptional repressor [20]. In the mouse, Sall4 and Tbx5 colocalize and interact physically [14].
###end p 34
###begin p 35
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 665 671 665 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SALL4 </italic>
###xml 703 708 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 854 864 854 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, 3B, 3C</xref>
###xml 891 901 891 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D, 3E, 3F</xref>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
###xml 778 782 <span type="species:ncbi:9925">goat</span>
###xml 788 793 <span type="species:ncbi:10090">mouse</span>
In order to analyze the mutated TBX5 protein for possible impaired nuclear localization we transfected COS-7 cells with TBX5-GFP wild type or mutant constructs and analyzed the intracellular distribution of the proteins by use of confocal laser scanning microscopy (CLSM, Fig. 2). The distribution of TBX5 wild type (Fig. 2A) and mutant proteins (Fig. 2B) both appeared as dot-like structures in the nucleus. Transfection of the empty GFP vector was used as negative control, and resulted in a diffuse nuclear staining (Fig. 2C). To assess whether the intranuclear distribution of mutated TBX5 differs from the wild type protein, we co-transfected COS-7 cells with SALL4 and either wild type or mutated TBX5 constructs. SALL4 was detected by use of mouse anti-FLAG antibody and goat anti-mouse IgG-TRITC. An overlay of the SALL4 and TBX5 wild type (Fig. 3A, 3B, 3C) and mutant signals (Fig. 3D, 3E, 3F) demonstrated co-localization of both proteins, respectively. Thus, the mutation c.1333delC does not affect the transport of the protein to the nucleus nor its intranuclear distribution.
###end p 35
###begin p 36
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intracellular localization of wild type and mutant TBX5</bold>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
Intracellular localization of wild type and mutant TBX5. (A) COS-7 cells were transfected with TBX5 fused to the sequence encoding the green fluorescent protein (GFP). Wild type TBX5 appeared in dot-like structures in the nuclei (blue, stained with DAPI) of the analyzed cells. (B) The mutant TBX5 displays a distinct and homogenous arrangement in the nucleus, the distribution pattern does not differ compared to the wild type TBX5. (C) The empty pEGFP-N3-vector was transfected as a negative control and resulted in a diffuse nuclear staining.
###end p 36
###begin p 37
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Co-localization of wild type and mutant TBX5 with SALL4</bold>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SALL4</italic>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 278 282 <span type="species:ncbi:9925">goat</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
Co-localization of wild type and mutant TBX5 with SALL4. The subcellular distribution of the proteins was analyzed in COS-7 cells transfected with either wild type or mutant TBX5-GFP constructs and SALL4-FLAG. SALL4 was detected using mouse alpha-FLAG antiserum and a secondary goat anti-mouse TRITC-labelled antibody. SALL4 and TBX5 (A, B, C) form overlapping distinct structures in the nucleus. The SALL4 signal was also shown to interfere with subcellular distribution of the mutated TBX5 in dot-like structures in the nucleus (D, E, F). The nuclei, stained with DAPI, appear in blue.
###end p 37
###begin title 38
c.1333delC mutation impairs activation of the ANF promoter
###end title 38
###begin p 39
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 469 472 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ANF</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ANF </italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 674 693 674 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla reniformis </italic>
###xml 916 921 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 1005 1009 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5</italic>
###xml 1230 1234 1230 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5</italic>
###xml 1381 1385 1381 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5</italic>
###xml 1491 1492 1491 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1625 1629 1625 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ANF </italic>
###xml 674 692 <span type="species:ncbi:6136">Renilla reniformis</span>
An important functional domain of TBX5 is the T-box motif involved in DNA-binding and protein-protein interactions [10,11]. The majority of the described TBX5 mutations result in preterminal stop codons. The functional effect of the c.1333delC mutation - leading to an elongated protein - on transcriptional regulation was assessed using a luciferase assay. COS-7 cells were transiently co-transfected with mutant/wild type TBX5 expression constructs (pFLAG-N3) and an ANF-luciferase construct as reporter. The upstream region of the ANF (atrial natriuretic factor gene) promoter contains a TBX5 binding site [21]. The luciferase activity was normalized in reference to the Renilla reniformis luciferase activity, used as an internal control. The constructs were analyzed by immunoblot for appropriate expression (data not shown). Reporter gene activation significantly increased in cells transfected with wild type TBX5 compared to cells transfected with the empty expression vector. Transfection of the TBX5-GFP construct lead to the same result, indicating that neither the FLAG-tag nor the GFP-tag (as used in the localization studies) have a detrimental effect on the protein function. The luciferase activity of the mutated TBX5-FLAG construct was strongly reduced to a value comparable to cells transfected with the empty pFLAG-N3 vector. An increased amount of transfected TBX5mut plasmid (300 ng, 450 ng, 600 ng) did not induce luciferase activity, ruling out a dosage effect (Fig. 4). Under the experimental conditions of cell culture mediated luciferase assays, the mutation c.1333delC abrogates activation of the ANF promoter by TBX5.
###end p 39
###begin p 40
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Functional effect of the <italic>TBX5 </italic>c.1333delC mutation on transcriptional regulation</bold>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ANF </italic>
###xml 313 332 313 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla reniformis </italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 313 331 <span type="species:ncbi:6136">Renilla reniformis</span>
Functional effect of the TBX5 c.1333delC mutation on transcriptional regulation. COS-7 cells were transiently co-transfected either with mutant or wild type TBX5 expression constructs and a reporter encoding the luciferase gene under the control of the ANF promoter. Values were calculated by normalizing against Renilla reniformis luciferase activity and compared to the empty FLAG vector (column 1). Wild type TBX5-FLAG and TBX5-GFP effectively induced expression of the reporter gene (columns 2 and 3), whereas cells transfected with rising amounts of the mutant TBX5 construct demonstrated entire abrogation of reporter gene activation compared to wild type TBX5 (column 4, 5, 6).
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5</italic>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 742 747 742 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 900 903 900 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ANF</italic>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1205 1207 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1256 1264 1256 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 1282 1284 1282 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fs</italic>
###xml 1381 1386 1381 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 1415 1418 1415 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ANF</italic>
Autosomal dominant Holt-Oram syndrome, linked to mutations in the T-box transcription factor gene TBX5, is characterized by bilateral forelimb malformations and congenital heart defects. Also defects of the pulmonary veins are common. Mutations found in TBX5 include missense, nonsense, frameshift and splice site mutations as well as large deletions (TBX5 gene mutation database; ) [4,6,22]. Mutations in the N-terminal region of the T-box affect binding of TBX5 to the major groove of DNA, while mutations in the C-terminal region of the T-box affect binding to the minor grove. There is no obvious genotype-phenotype correlation. The severity of limb and heart varies independently of type and location of the mutation [23]. Diverse known TBX5 missense mutations (p.Q49K, p.I54T, p.G80R, p.G169R, p.R237Q, p.R237W, and p.S252I) reduce synergistic transcriptional activity of the downstream target ANF, but only the mutations p.G80R, p.R237Q, and p.R237W were shown to affect DNA-binding [13]. In addition, an impaired nuclear localization of the altered proteins was demonstrated. Similar results were obtained by functional analysis of the in-frame mutation 381-408del (c.376_402del, p.K126_R134del) [13]. To assess a putative functional effect of the de novo c.1333delC (p.H445fsX136) mutation on transcriptional activation we co-transfected COS-7 cells with mutant/wild type TBX5 expression constructs and an ANF-luciferase construct. Under the experimental conditions of the luciferase assay, the reporter gene activation through the mutated TBX5 protein was abrogated and non functional as compared to the wild type protein.
###end p 42
###begin p 43
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1218 1223 1218 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 1464 1466 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1661 1665 1661 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5</italic>
###xml 1979 1984 1979 1984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 1609 1616 <span type="species:ncbi:9606">patient</span>
###xml 2151 2158 <span type="species:ncbi:9606">patient</span>
The human TBX5 gene consists of 8 coding exons and one 5' non-coding exon dispersed over 53 kilobases (kb) on chromosome 12q24. Proteins of the T-box family comprise two distinct structural and functional domains: the DNA-binding domain, referred as T-box, and a transcriptional activator or repressor domain [24]. Residues of the T-box are highly conserved throughout members of this family and across species. Binding-site selection experiments showed an affinity of T-box proteins for the consensus sequence TCACACCT [25]. The transcriptional regulation activity was shown to require sequence motifs within the C-terminal part of the protein [25]. For the development of specific organs like heart and upper limbs, TBX5 is an essential transcription factor. The import to the nucleus is thereby promoted by two distinct nuclear localization signals (NLS) working in concert. The two minimal sequences required for nuclear import were found to reside within (aa 79-90) and carboxyl to the T-box (325-340). The first amino acid affected by the mutation c.1333delC (His445) is carboxyterminal of both regions required for nuclear localization. This mutation resides within the last exon, we therefore assume, that the TBX5 mRNA bearing the single nucleotide deletion is not degraded by nonsense mediated decay. This mechanism was shown to occur only in case that the preterminal stop codon is located at least 50-55 nucleotides before the last exon/exon boundary [26]. Thus, messenger RNAs with nonsense mutations or small deletions/insertions in the last exon are generally translated into a protein. As the patient's deletion was detected in the last exon of TBX5, the mRNA is predicted to result in a elongated protein consisting of 580 instead of 518 amino acids. It is conceivable that an altered protein configuration or steric hindrance may silence the activity of the NLS motifs. We therefore wanted to analyze the intracellular distribution of the mutated TBX5 protein. TBX5 is mainly expressed during embryonic morphogenesis and is limited to esophagus, heart, liver, lung, prostate and trachea in the adult organism. Blood samples from the patient were taken for DNA sequence analysis, but could not be used for investigations on the TBX5 protein as it is not detectable in lymphocytes. Consequently we did not have the possibility to analyze the presence and the intracellular localization of the endogenous elongated protein. Other possible TBX5 sources were not available. All experiments were therefore carried out by transfecting wild type and mutated fusion constructs into an appropriate cell line.
###end p 43
###begin p 44
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 151 157 <span type="species:ncbi:10090">murine</span>
Both wild type as well as mutated TBX5 proteins were found to localize in dot-like structures within the nucleus, and both co-localize with SALL4. The murine homologue Sall4 was previously demonstrated to localize to heterochromatin and to operate as a transcriptional repressor [20].
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
Interestingly, four other truncating mutations have been detected in exon 9 of the TBX5 gene (c.1024delT, c.1084C>T, c.1159dupA, c.1366C>T) so far to our knowledge. All result in shortening of the TBX5 protein. However, it is unclear how those lead to TBX5 haploinsufficiency, since the mutations will most likely not lead to nonsense-mediated mRNA decay, because they reside within the most 3' positioned exon. The unique mutation c.1333delC differs from the other mutations in exon 9 as it leads to an elongated protein. Since the mutation neither affects the intranuclear distribution of TBX5 nor its colocalization with SALL4, but abrogates activation of the ANF promoter, it is tempting to speculate that the supernumerary amino acids modulate the configuration of the protein by masking the transcriptional activator domain.
###end p 46
###begin title 47
Competing interests
###end title 47
###begin p 48
The authors declare that they have no competing interests.
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
JB conceived of the study, carried out the functional molecular genetic studies and drafted the manuscript. WH and UF accomplished the sequence analysis and wrote the clinical section of the manuscript. AC participated in the functional molecular genetic studies. MV and BMEJ collected the clinical data. JK coordinated the project and participated in the manuscript preparation.
###end p 50
###begin title 51
Consent
###end title 51
###begin p 52
###xml 54 61 <span type="species:ncbi:9606">patient</span>
Written consent for publication was obtained from the patient's parents.
###end p 52
###begin title 53
Pre-publication history
###end title 53
###begin p 54
The pre-publication history for this paper can be accessed here:
###end p 54
###begin p 55

###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
Additional file 1
###end title 57
###begin p 58
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The c.1333delC mutation results in an elongated protein</bold>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBX5 </italic>
The c.1333delC mutation results in an elongated protein. The heterozygous c.1333delC mutation (yellow) in exon 9 of TBX5 results in a translational frameshift creating an elongated TBX5 protein due to a downstream shift of the termination codon. The mutant TBX5 protein contains 74 miscoding amino acids and 62 supernumerary C-terminal amino acids (black letters).
###end p 58
###begin p 59
Click here for file
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
We thank the family for their cooperation, Benoit Bruneau for providing the ANF-luciferase construct and Valerie Tosch for technical assistance. Contract grant sponsor: Deutsche Forschungsgemeinschaft, grant no. KO1850/6-1,2 to JK.
###end p 61
###begin article-title 62
###xml 13 18 <span type="species:ncbi:9606">human</span>
Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome
###end article-title 62
###begin article-title 63
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family
###end article-title 63
###begin article-title 64
###xml 32 37 <span type="species:ncbi:9606">human</span>
Causes of clinical diversity in human TBX5 mutations
###end article-title 64
###begin article-title 65
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human TBX5 gene mutation database
###end article-title 65
###begin article-title 66
Detection of a large TBX5 deletion in a family with Holt-Oram syndrome
###end article-title 66
###begin article-title 67
Expanding the spectrum of TBX5 mutations in Holt-Oram syndrome: detection of two intragenic deletions by quantitative real time PCR, and report of eight novel point mutations
###end article-title 67
###begin article-title 68
The genetic contribution to congenital heart disease
###end article-title 68
###begin article-title 69
Somatic mutations in cardiac malformations
###end article-title 69
###begin article-title 70
TBX5 Genetic Testing Validates Strict Clinical Criteria for Holt-Oram Syndrome
###end article-title 70
###begin article-title 71
Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome
###end article-title 71
###begin article-title 72
###xml 2 8 <span type="species:ncbi:10090">murine</span>
A murine model of Holt-Oram syndrome defines roles of the T-Box transcription factor Tbx5 in cardiogenesis and disease
###end article-title 72
###begin article-title 73
Novel TBX5 mutations and molecular mechanism for Holt-Oram syndrome
###end article-title 73
###begin article-title 74
Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome
###end article-title 74
###begin article-title 75
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart
###end article-title 75
###begin article-title 76
###xml 22 27 <span type="species:ncbi:9606">human</span>
GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5
###end article-title 76
###begin article-title 77
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome
###end article-title 77
###begin article-title 78
TBX5 nuclear localization is mediated by dual cooperative intramolecular signals
###end article-title 78
###begin article-title 79
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Identification of new mutations in the TBX5 gene in patients with Holt-Oram syndrome
###end article-title 79
###begin article-title 80
###xml 68 73 <span type="species:ncbi:9606">human</span>
Identification and localization of TBX5 transcription factor during human cardiac morphogenesis
###end article-title 80
###begin article-title 81
Synergistic cooperation of Sall4 and Cyclin D1 in transcriptional repression
###end article-title 81
###begin article-title 82
Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation
###end article-title 82
###begin article-title 83
Contiguous hemizygous deletion of TBX5, TBX3, and RBM19 resulting in a combined phenotype of Holt-Oram and ulnar-mammary syndromes
###end article-title 83
###begin article-title 84
Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype
###end article-title 84
###begin article-title 85
The T-box family
###end article-title 85
###begin article-title 86
Determinants of T box protein specificity
###end article-title 86
###begin article-title 87
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
###end article-title 87

